SG11201602998QA - Genetic markers for antipsychotic induced weight gain and methods for use thereof - Google Patents

Genetic markers for antipsychotic induced weight gain and methods for use thereof

Info

Publication number
SG11201602998QA
SG11201602998QA SG11201602998QA SG11201602998QA SG11201602998QA SG 11201602998Q A SG11201602998Q A SG 11201602998QA SG 11201602998Q A SG11201602998Q A SG 11201602998QA SG 11201602998Q A SG11201602998Q A SG 11201602998QA SG 11201602998Q A SG11201602998Q A SG 11201602998QA
Authority
SG
Singapore
Prior art keywords
methods
weight gain
genetic markers
induced weight
antipsychotic induced
Prior art date
Application number
SG11201602998QA
Inventor
Clement C Zai
James L Kennedy
Daniel J Mueller
Original Assignee
Camh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Camh filed Critical Camh
Publication of SG11201602998QA publication Critical patent/SG11201602998QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201602998QA 2013-10-17 2014-10-17 Genetic markers for antipsychotic induced weight gain and methods for use thereof SG11201602998QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361892094P 2013-10-17 2013-10-17
PCT/CA2014/051000 WO2015054792A1 (en) 2013-10-17 2014-10-17 Genetic markers for antipsychotic induced weight gain and methods for use thereof

Publications (1)

Publication Number Publication Date
SG11201602998QA true SG11201602998QA (en) 2016-05-30

Family

ID=52827506

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201602998QA SG11201602998QA (en) 2013-10-17 2014-10-17 Genetic markers for antipsychotic induced weight gain and methods for use thereof

Country Status (12)

Country Link
US (1) US10301678B2 (en)
EP (2) EP3561076A1 (en)
JP (1) JP6524073B2 (en)
KR (1) KR102252926B1 (en)
CN (1) CN106029901A (en)
AU (1) AU2014336928B2 (en)
CA (1) CA2943951C (en)
ES (1) ES2728072T3 (en)
IL (1) IL245159B (en)
PT (1) PT3058106T (en)
SG (1) SG11201602998QA (en)
WO (1) WO2015054792A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3090203A1 (en) * 2018-02-09 2019-08-15 Metabolomic Diagnostics Limited Methods of predicting pre term birth from preeclampsia using metabolic and protein biomarkers
CN110317868B (en) * 2019-08-09 2020-05-19 新疆医科大学第二附属医院 Analysis method for predicting weight gain caused by schizophrenia treated by second-generation antipsychotic drugs based on polygene combination interaction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
CA2176348C (en) 1993-11-12 2004-11-02 Sanjay Tyagi Hybridization probes for nucleic acid detection, universal stems, methods and kits
US20030104453A1 (en) * 2001-11-06 2003-06-05 David Pickar System for pharmacogenetics of adverse drug events
US8012718B2 (en) 2006-03-31 2011-09-06 Genomas, Inc. Physiogenomic method for predicting diabetes and metabolic syndromes induced by psychotropic drugs
US20070292962A1 (en) * 2006-04-10 2007-12-20 Duke University Methods and compositions for genetic markers for autism
US7795033B2 (en) 2007-03-19 2010-09-14 The United States Of America As Represented By The Department Of Health And Human Services Methods to predict the outcome of treatment with antidepressant medication
US8476012B2 (en) 2008-04-18 2013-07-02 Genomas, Inc. Physiogenomic method for predicting metabolic and cardiovascular side effects of thiazolidinediones
US8355927B2 (en) 2010-11-05 2013-01-15 Genomind, Llc Neuropsychiatric test reports
JP2015501652A (en) * 2011-12-14 2015-01-19 アストラゼネカ・アクチエボラーグAstrazeneca Aktiebolag GABR-A2 diagnosis

Also Published As

Publication number Publication date
JP6524073B2 (en) 2019-06-05
KR20160098188A (en) 2016-08-18
IL245159B (en) 2020-10-29
US20160237499A1 (en) 2016-08-18
CA2943951A1 (en) 2015-04-23
PT3058106T (en) 2019-05-30
EP3058106A1 (en) 2016-08-24
CA2943951C (en) 2022-05-31
ES2728072T3 (en) 2019-10-22
WO2015054792A1 (en) 2015-04-23
AU2014336928B2 (en) 2020-07-16
EP3561076A1 (en) 2019-10-30
CN106029901A (en) 2016-10-12
EP3058106A4 (en) 2017-06-07
US10301678B2 (en) 2019-05-28
IL245159A0 (en) 2016-06-30
KR102252926B1 (en) 2021-05-20
JP2016534715A (en) 2016-11-10
EP3058106B1 (en) 2019-02-27

Similar Documents

Publication Publication Date Title
HK1218917A1 (en) Jak2 and alk2 inhibitors and methods for their use jak2 alk2
PT3008187T (en) Soybean transgenic event mon87751 and methods for detection and use thereof
EP2828258A4 (en) Novelpyridopyrimidine derivatives and use thereof
GB201318201D0 (en) Weight Sensing
HK1201521A1 (en) Heterocyclic compounds and methods for their use
HK1201533A1 (en) Heterocyclic compounds and methods for their use
HK1201531A1 (en) Heterocyclic compounds and methods for their use
AP2016009207A0 (en) Genetic markers and uses therefor
PL2964767T3 (en) Toxin genes and methods for their use
IL243433A0 (en) Tib2 layres and use thereof
PT2708607T (en) Genetic markers for myb28
HK1203486A1 (en) Benzoheterocyclic compounds and use thereof
ZA201405392B (en) Substituted phenylimidazopyrazoles and use thereof
IL246417A0 (en) Genetic markers associated with suicide risk and methods of use thereof
SG10201708046YA (en) Nanoprobe-Based Genetic Testing
IL245159B (en) Genetic markers for antipsychotic induced weight gain and methods for use thereof
EP2971114A4 (en) Methods and compositions for evaluating genetic markers
HK1213573A1 (en) Gene mutant and use thereof
EP3065826A4 (en) Genetic markers of antipsychotic response
TWI559851B (en) Watering and feeding dual-purpose vessel construction
GB201204745D0 (en) Identifying proximity and location